Bringing CMOs and CFOs Together: How Strong C-Suite Relationships Trigger High Growth Cannabis Companies

Key Insights

• The CMO-CFO tension in cannabis companies most often originates from a shared measurement problem: marketing cannot prove long-term brand ROI in the terms finance understands, and finance cannot see the brand-building investment that prevents the more expensive customer acquisition costs that would occur without it.
• Cannabis CMOs who present marketing investment in financial terms, including customer acquisition cost, customer lifetime value, payback period, and channel-level ROAS, build significantly more CFO trust than those who present marketing in brand equity or awareness terms that finance cannot connect to balance sheet or P&L impact.
• Cannabis CFOs who understand that some marketing investment produces returns over a 12 to 36 month horizon rather than a 30-day cycle will prevent the short-term budget cuts that undermine the brand-building work that makes long-term profitable growth possible.
• Shared attribution infrastructure that both the CMO and CFO trust is the most practical solution to the measurement problem underlying most CMO-CFO conflict in cannabis: when both leaders can see the same revenue-connected marketing data, budget discussions become more collaborative and less adversarial.
• The cannabis companies with the strongest C-suite marketing-finance alignment tend to have formal quarterly marketing performance reviews where CMO and CFO look at the same data together, creating shared understanding of what is working and why budget decisions are being made.

Expert Answers

[{Why do CMOs and CFOs often disagree about cannabis marketing investment?}

CMOs and CFOs disagree about cannabis marketing investment primarily because they are measuring different things on different time horizons. The CMO sees brand awareness, community growth, and the long-term customer acquisition cost reduction that sustained brand investment produces. The CFO sees quarterly P&L, marketing line items as a percentage of revenue, and demands for direct attribution of spend to measurable revenue outcomes. In cannabis, where third-party tracking limitations and long customer lifetime value cycles make direct attribution more complex than in many consumer categories, this measurement gap produces recurring budget conflict that slows marketing investment decisions and underinvests in brand building that would produce returns on a longer horizon.

{How can cannabis CMOs build more trust with their CFO?}

Cannabis CMOs build CFO trust by adopting financial language and presenting marketing performance in terms the CFO finds credible: customer acquisition cost by channel, customer lifetime value by segment, marketing payback period, channel-level ROAS, and incremental revenue attributed to specific marketing investments. CMOs who present a marketing investment case in financial terms rather than brand awareness terms give the CFO a framework for evaluating marketing that fits within their existing analytical approach. Building shared attribution infrastructure that the CMO and CFO both trust as the measurement standard eliminates the credibility gap that typically fuels C-suite marketing budget conflict.

{What financial metrics should cannabis marketing teams track?}

Cannabis marketing teams should track the metrics that matter most to financial leadership, including customer acquisition cost by channel, average customer lifetime value by acquisition segment, marketing return on ad spend by campaign type, customer payback period (how long it takes for a customer's revenue to exceed their acquisition cost), total marketing spend as a percentage of revenue by channel, and the incrementality of marketing investment (how much revenue would have been lost without the marketing activity). Teams that report on these metrics alongside standard marketing performance metrics demonstrate financial fluency that builds CFO confidence and marketing budget credibility.

{How do cannabis companies build shared marketing-finance alignment?}

Cannabis companies build shared marketing-finance alignment through formal quarterly reviews where CMO and CFO examine the same performance data together, shared investment frameworks that both leaders co-develop and co-own, clear definitions of how marketing success is measured that both functions agree to before campaigns launch, and governance processes that give the CFO visibility into marketing budget allocation decisions and the CMO visibility into financial constraints before they become budget cuts. Companies that institutionalize this shared data and shared conversation reduce the adversarial dynamic that characterizes poorly aligned CMO-CFO relationships in cannabis.]

Webinar Highlights

00:00 - The CMO-CFO Dynamic in Cannabis Companies

The session opens with an honest assessment of why the relationship between marketing and finance leadership is particularly strained in cannabis companies, what the common conflict patterns look like, and what the business cost of poorly aligned CMO-CFO relationships is in terms of missed marketing investment and slowed growth.

08:00 - Speaking Finance's Language as a Cannabis CMO

This section covers how cannabis marketing leaders can present their strategies, investment cases, and performance reports in financial terms that CFOs find credible, including the specific metrics and frameworks that translate marketing strategy into finance-legible business impact.

18:00 - What CFOs Need to Understand About Brand Investment

The webinar examines the nature of brand investment and its long-cycle returns, helping financial leaders understand why some marketing investments that appear to have uncertain short-term ROI are producing the brand equity and customer acquisition cost advantages that will be visible on the P&L over a 12 to 36 month horizon.

26:00 - Building Shared Attribution Infrastructure

This section covers the measurement infrastructure investments that create a shared data foundation for CMO-CFO alignment, including how attribution systems that connect marketing spend to revenue outcomes remove the credibility gap that fuels most C-suite marketing budget disagreements.

34:00 - Creating a Governance Process for Marketing-Finance Alignment

The session closes with the specific organizational practices, review cadences, and co-ownership frameworks that cannabis companies with strong CMO-CFO alignment have institutionalized, providing a model for cannabis operators who want to replace adversarial budget conflict with collaborative marketing investment decision-making.

Frequently Asked Questions

[ {What is marketing ROI in cannabis and how do you calculate it?}

Marketing ROI in cannabis is the revenue return generated by marketing investment relative to the cost of that investment. It is calculated by dividing the revenue attributed to marketing-driven customer acquisition and retention by the total marketing spend that produced those customers, expressed as a ratio or percentage. For example, if $100,000 in marketing spend produced $400,000 in attributed revenue from newly acquired and reactivated customers, the marketing ROI is 4x or 300 percent net return on investment. Cannabis marketing ROI calculation requires reliable attribution infrastructure that connects ad spend to POS revenue at the customer level, making attribution investment a prerequisite for credible ROI reporting.

{How much of revenue should a cannabis company spend on marketing?}

Cannabis company marketing spend as a percentage of revenue varies significantly by stage, market position, and growth objectives, making any single benchmark of limited value. Early-stage dispensaries in competitive markets may need to invest 10 to 20 percent of revenue to build awareness and customer base. Established dispensaries in mature markets often operate at 5 to 8 percent. Cannabis brands with DTC ambitions or national distribution goals may invest 15 to 25 percent in brand-building and customer acquisition. The more useful framework is not a revenue percentage target but a marketing economics assessment: is the company spending at a rate that produces positive customer acquisition economics, sustainable lifetime value, and improving unit economics over time?

{What is the payback period for cannabis marketing investment?}

The payback period for cannabis marketing investment is the time it takes for the revenue generated by a marketing-acquired customer to exceed the cost of acquiring that customer. If a dispensary spends $75 on average to acquire a new customer through programmatic advertising, and that customer generates $50 in gross margin on their first visit and $30 in gross margin per visit on average thereafter, the payback period is roughly two to three visits or 60 to 90 days for a customer who visits monthly. Understanding payback period by acquisition channel helps cannabis CMOs and CFOs align on how long marketing investment should be evaluated before drawing conclusions about channel-level performance and allocation decisions.

{How do cannabis companies evaluate new marketing channel investments?}

Cannabis companies evaluate new marketing channel investments through a structured test framework that defines in advance the success metrics, minimum test budget, measurement timeline, and exit criteria for the channel trial. A 60 to 90 day test with a predefined budget allows enough time to generate meaningful performance data without committing to the channel before results are available. The evaluation should compare the new channel's cost-per-acquisition and ROAS to the company's existing best-performing channels, using the same attribution methodology to ensure a fair comparison. Channels that meet or exceed the predefined success criteria within the test window earn expanded investment; those that fall short are either retested with a different approach or deprioritized. ]